Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

16.7%

2 terminated out of 12 trials

Success Rate

60.0%

-26.6% vs benchmark

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

60% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (2)
P 2 (3)
P 4 (2)

Trial Status

Recruiting4
Completed3
Terminated2
Unknown1
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

60.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT07157670Recruiting

Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

NCT07839130Phase 2Not Yet RecruitingPrimary

PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide

NCT05806138Phase 2Active Not Recruiting

A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction

NCT03790943RecruitingPrimary

Cardiac Dysfunction in Childhood Cancer Survivors

NCT07110415Phase 4Recruiting

Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

NCT05659589Not ApplicableRecruiting

Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury

NCT03866564CompletedPrimary

Football Players Health Study In Person Assessments Study

NCT04433546Phase 2Terminated

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

NCT02581280CompletedPrimary

Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

NCT03085420Not ApplicableTerminatedPrimary

Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient

NCT02320539Completed

MicroRNA Diagnostics in Subarachnoid Hemorrhage 2

NCT02144766Phase 4UnknownPrimary

Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block

Showing all 12 trials

Research Network

Activity Timeline